A Phase I, Open Label, Fixed-Sequence Study to Estimate the Effect of Tacrolimus and Cyclosporine on the Pharmacokinetics of CP-690,550 in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2009
At a glance
- Drugs Tofacitinib (Primary) ; Ciclosporin; Tacrolimus
- Indications Transplant rejection
- Focus Pharmacokinetics
- Sponsors Pfizer
- 14 Aug 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Jul 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 15 Apr 2009 Planned initiation date changed from 1 Mar 2009 to 1 Jun 2009 as reported by ClinicalTrials.gov.